Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats

Inflammation Research

Volumn 55, Issue 11, 2006, Pages 498-503

  Anuar, F ^a   Whiteman, M ^a   Bhatia, M ^a   Moore, P K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Caecal ligation puncture induced sepsis; Interleukin 1 ; Nitric oxide; Nitroflurbiprofen (HCT 1026); Tumour necrosis factor

Indexed keywords

FLURBIPROFEN; FLURBIPROFEN 4 NITROXYBUTYL ESTER; INTERLEUKIN 1BETA; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; INFLAMMATORY DISEASE; LIGATION; LIVER INJURY; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SEPTIC SHOCK; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CECUM; DISEASE MODELS, ANIMAL; FLURBIPROFEN; INTERLEUKIN-1BETA; LIGATION; MALE; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37849189372     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-5150-y     Document Type: Article

References (25)

1. Keeble JE., Moore PK. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 2002; 137: 295-310.
2. Burgaud JL, Ongini E, Del Soldato P. Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents. Ann NY Acad Sci 2002; 962: 360-71.
3. Fries J, Singh G, Ramey D. The clinical epidemiology of non-steroidal anti-inflammatory drug gastropathy. Clinical Significance and potential of selective COX-2 inhibitors. The William Harvey Press, London 1998; 557-73.
4. Fiorucci S, Antonelli E, Santucci I, Morelli O, Migletti M, Federici B et al. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology 1999; 116: 1089-106.
5. Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses. J Physiol Pharmacol 1998; 49: 501-13.
6. Al-Swayeh OA, Clifford RH, Moore PK. Anti-oedema and anti-nociceptive effect of nitroprednisone and nitroflurbiprofen. Br J Pharmacol 1999; 127: 84.
7. Al-Swayeh OA, Clifford RH, Del Soldato P, Moore PK. A comparison of the antiinflammatory and antinociceptive activity of nitroaspirin and aspirin. Br J Pharmacol 1999; 129: 343-50.
8. Yuan J, Murrell GA, Wei AQ, Appleyard RC, Del Soldato P, Wang MX. Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons. Inflamm Res 2003; 52: 230-7.
9. Paul-Clark MJ, Mancini L, Del Soldato P, Flower RJ, Perretti M. Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis. Proc Natl Acad Sci USA 2000; 99: 1677-82.
10. Wallace JL, Rizzo G, Cirino G, Del Soldato P, Fiorucci S. Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB. J Pharmacol Exp Ther 2004; 310; 1096-102.
11. Rees DD. Role of nitric oxide in the vascular dysfunction of septic shock. Biochem Soc Trans 1995; 23: 1025-9.
12. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995; 34: 155-70.
13. Zhou M, Chaudry IH, Wang P. The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am J Physiol Regul Integr Comp Physiol 2001; 281: R654-R60.
14. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
15. Esmon CT. Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med 2004; 32: S219-22.
16. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21: S423-35.
17. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-95.
18. Pruitt JH, Copeland 3rd EM, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 1995; 3: 235-51.
19. McMasters KM, Peyton JC, Hadjiminas DJ, Cheadle WG. Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture. Cytokine 1994; 6: 530-6.
20. Cirino G, Wheeler-Jones CP, Wallace JL, Del Soldato P, Baydoun AR. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Br J Pharmacol 1996; 117: 1421-6.
21. Mariotto S, Cuzzolin L, Adami A, Del Soldato P, Suzuki H, Benoni G. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 1995; 115: 225-6.
22. Fratelli M, Minto M, Crespi A, Erba E, Vandenabeele P, Del Soldato P et al. Inhibition of nuclear factor-kappa B by a nitro-derivative of flurbiprofen: a possible mechanism for antiinflammatory and antiproliferative effect. Antioxid Redox Signal 2003; 5: 229-35.
23. Koo DJ, Zhou M, Jackman D, Cioffi WG, Bland KI, Chaudry IH et al. Is gut the major source of proinflammatory cytokine release during polymicrobial sepsis? Biochim Biophys Acta 1999; 1454: 289-95.
24. Marshall M, Moore PK. Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood. Eur J Pharmacol 2004; 483: 317-22.
25. Fiorucci S, Mencarelli A, Meneguzzi A, Lechi A, Morelli A, Del Soldato P et al. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation 2002; 106: 3120-5.